Press releases
- BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver
- BioLife Solutions Reports First Quarter 2024 Financial Results
- BioLife Solutions to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024
- BioLife Solutions Announces the Divestiture of its Stirling Freezer Business
Key statistics
As of last trade BioLife Solutions Inc (BJX1:FRA) traded at 18.70, -16.52% below its 52-week high of 22.40, set on Jun 14, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 18.70 |
---|---|
High | 18.70 |
Low | 18.70 |
Bid | 18.70 |
Offer | 19.10 |
Previous close | 18.90 |
Average volume | 10.43 |
---|---|
Shares outstanding | 46.03m |
Free float | 44.44m |
P/E (TTM) | -- |
Market cap | 991.51m USD |
EPS (TTM) | -1.43 USD |
Data delayed at least 15 minutes, as of Jun 10 2024 07:00 BST.
More ▼